Neuphoria Therapeutics (NEUP) Other Non-Current Liabilities (2023 - 2026)
Neuphoria Therapeutics (NEUP) reported Other Non-Current Liabilities of $1.97 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 46.7% from $3.7 million a year earlier and down 19.8% from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Other Non-Current Liabilities (2023 - 2026) Analysis & Trends
Dating back to fiscal Q4 2023, Neuphoria Therapeutics' Other Non-Current Liabilities record includes 10 quarters.
- Other Non-Current Liabilities has a three-year compound annual growth rate of -7.1% (FY2023 to FY2026).
- By fiscal year, Other Non-Current Liabilities came in at $3.7 million in FY2025 (-20.5%), $4.66 million in FY2024 (+89.6%) and $2.46 million in FY2023.
- The fiscal Q4 2026 figure ranks as the lowest quarterly Other Non-Current Liabilities since fiscal Q3 2025.
- Year over year, Other Non-Current Liabilities gained in three of the last five quarters, with growth averaging 115.2%.
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $2.46 million (Q3 2026), $2.71 million (Q2 2026) and $8.09 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Neuphoria Therapeutics | 443.79 Mn | 368.60 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.97 Mn |
| Mar 31, 2026 | 2.46 Mn |
| Dec 31, 2025 | 2.71 Mn |
| Sep 30, 2025 | 8.09 Mn |
| Jun 30, 2025 | 3.70 Mn |
| Mar 31, 2025 | 1.89 Mn |
| Dec 31, 2024 | 810,125.00 |
| Sep 30, 2024 | 1.69 Mn |
| Jun 30, 2024 | 4.66 Mn |
| Jun 30, 2023 | 2.46 Mn |
API Access
Neuphoria Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();